Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
12489 | 902 | 28.5 | 73% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
236 | 3 | ADENOSINE//NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS//ADENOSINE RECEPTORS | 48331 |
793 | 2 | NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS//NUCLEOSIDES//CARBOCYCLIC NUCLEOSIDES | 12112 |
12489 | 1 | PRONUCLEOTIDES//PHOSPHORAMIDATE//PROTIDE | 902 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PRONUCLEOTIDES | authKW | 825316 | 4% | 76% | 32 |
2 | PHOSPHORAMIDATE | authKW | 688167 | 8% | 29% | 70 |
3 | PROTIDE | authKW | 436430 | 2% | 68% | 19 |
4 | AZT | authKW | 263137 | 6% | 14% | 54 |
5 | PRODRUG | authKW | 222852 | 14% | 5% | 126 |
6 | UMR 5625 | address | 215630 | 3% | 22% | 29 |
7 | NUCLEOTIDE PRODRUG | authKW | 210915 | 1% | 69% | 9 |
8 | HYDROGENPHOSPHONATE METHOD | authKW | 174092 | 1% | 86% | 6 |
9 | CYCLOSAL | authKW | 152329 | 1% | 75% | 6 |
10 | REGA MED | address | 145605 | 13% | 4% | 115 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 8496 | 29% | 0% | 261 |
2 | Chemistry, Organic | 3592 | 29% | 0% | 263 |
3 | Biochemistry & Molecular Biology | 1011 | 30% | 0% | 274 |
4 | Pharmacology & Pharmacy | 920 | 21% | 0% | 185 |
5 | Virology | 861 | 8% | 0% | 71 |
6 | Chemistry, Multidisciplinary | 218 | 13% | 0% | 116 |
7 | Biochemical Research Methods | 10 | 2% | 0% | 19 |
8 | Biophysics | 4 | 2% | 0% | 18 |
9 | Chemistry, Analytical | 4 | 3% | 0% | 23 |
10 | Chemistry, Inorganic & Nuclear | 1 | 2% | 0% | 14 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | UMR 5625 | 215630 | 3% | 22% | 29 |
2 | REGA MED | 145605 | 13% | 4% | 115 |
3 | UMR CNRS USTL 5625 | 138221 | 1% | 58% | 7 |
4 | MINIST EDUC BIOORGAN PHOSPHORUS CHEM | 113346 | 1% | 28% | 12 |
5 | U74INSERM | 101554 | 0% | 100% | 3 |
6 | BIOORGAN PHOSPHORUS CHEMMINIST EDUC | 76930 | 1% | 45% | 5 |
7 | WELSH PHARM | 72864 | 5% | 5% | 47 |
8 | COOPERATIF NOVIRIO | 67703 | 0% | 100% | 2 |
9 | LIFE SCI ENGNMINIST EDUC | 67703 | 0% | 100% | 2 |
10 | ORGAN FUNCT MOL | 67703 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS | 120946 | 14% | 3% | 129 |
2 | ANTIVIRAL CHEMISTRY & CHEMOTHERAPY | 98680 | 4% | 8% | 38 |
3 | JOURNAL OF MEDICINAL CHEMISTRY | 14201 | 11% | 0% | 95 |
4 | ANTIVIRAL RESEARCH | 8183 | 3% | 1% | 29 |
5 | NUCLEOSIDES & NUCLEOTIDES | 6138 | 1% | 2% | 11 |
6 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 5273 | 7% | 0% | 63 |
7 | BIOORGANIC & MEDICINAL CHEMISTRY | 2794 | 4% | 0% | 33 |
8 | ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH | 1290 | 1% | 0% | 9 |
9 | CHEMMEDCHEM | 1181 | 1% | 0% | 9 |
10 | RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY | 842 | 1% | 0% | 6 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PRONUCLEOTIDES | 825316 | 4% | 76% | 32 | Search PRONUCLEOTIDES | Search PRONUCLEOTIDES |
2 | PHOSPHORAMIDATE | 688167 | 8% | 29% | 70 | Search PHOSPHORAMIDATE | Search PHOSPHORAMIDATE |
3 | PROTIDE | 436430 | 2% | 68% | 19 | Search PROTIDE | Search PROTIDE |
4 | AZT | 263137 | 6% | 14% | 54 | Search AZT | Search AZT |
5 | PRODRUG | 222852 | 14% | 5% | 126 | Search PRODRUG | Search PRODRUG |
6 | NUCLEOTIDE PRODRUG | 210915 | 1% | 69% | 9 | Search NUCLEOTIDE+PRODRUG | Search NUCLEOTIDE+PRODRUG |
7 | HYDROGENPHOSPHONATE METHOD | 174092 | 1% | 86% | 6 | Search HYDROGENPHOSPHONATE+METHOD | Search HYDROGENPHOSPHONATE+METHOD |
8 | CYCLOSAL | 152329 | 1% | 75% | 6 | Search CYCLOSAL | Search CYCLOSAL |
9 | N P 4 BROMOPHENYL 2 3 DIDEHYDRO 3 DEOXY 5 THYMIDYLYL L ALANINE METHYL ESTER | 141046 | 1% | 83% | 5 | Search N+P+4+BROMOPHENYL+2+3+DIDEHYDRO+3+DEOXY+5+THYMIDYLYL+L+ALANINE+METHYL+ESTER | Search N+P+4+BROMOPHENYL+2+3+DIDEHYDRO+3+DEOXY+5+THYMIDYLYL+L+ALANINE+METHYL+ESTER |
10 | D4T | 138461 | 2% | 27% | 15 | Search D4T | Search D4T |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | PRADERE, U , GARNIER-AMBLARD, EC , COATS, SJ , AMBLARD, F , SCHINAZI, RF , (2014) SYNTHESIS OF NUCLEOSIDE PHOSPHATE AND PHOSPHONATE PRODRUGS.CHEMICAL REVIEWS. VOL. 114. ISSUE 18. P. 9154 -9218 | 202 | 60% | 76 |
2 | WAGNER, CR , IYER, VV , MCINTEE, EJ , (2000) PRONUCLEOTIDES: TOWARD THE IN VIVO DELIVERY OF ANTIVIRAL AND ANTICANCER NUCLEOTIDES.MEDICINAL RESEARCH REVIEWS. VOL. 20. ISSUE 6. P. 417 -451 | 101 | 78% | 180 |
3 | HECKER, SJ , ERION, MD , (2008) PRODRUGS OF PHOSPHATES AND PHOSPHONATES.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 51. ISSUE 8. P. 2328-2345 | 89 | 57% | 189 |
4 | PETERSON, LW , MCKENNA, CE , (2009) PRODRUG APPROACHES TO IMPROVING THE ORAL ABSORPTION OF ANTIVIRAL NUCLEOTIDE ANALOGUES.EXPERT OPINION ON DRUG DELIVERY. VOL. 6. ISSUE 4. P. 405-420 | 62 | 70% | 14 |
5 | CAHARD, D , MCGUIGAN, C , BALZARINI, J , (2004) ARYLOXY PHOSPHORAMIDATE TRIESTERS AS PRO-TIDES.MINI-REVIEWS IN MEDICINAL CHEMISTRY. VOL. 4. ISSUE 4. P. 371-381 | 54 | 79% | 105 |
6 | PARANG, K , WIEBE, LI , KNAUS, EE , (2000) NOVEL APPROACHES FOR DESIGNING 5 '-O-ESTER PRODRUGS OF 3'-AZIDO-2 ',3 '-DIDEOXYTHYMIDINE (AZT).CURRENT MEDICINAL CHEMISTRY. VOL. 7. ISSUE 10. P. 995 -1039 | 98 | 47% | 116 |
7 | MEHELLOU, Y , BALZARINI, J , MCGUIGAN, C , (2009) ARYLOXY PHOSPHORAMIDATE TRIESTERS: A TECHNOLOGY FOR DELIVERING MONOPHOSPHORYLATED NUCLEOSIDES AND SUGARS INTO CELLS.CHEMMEDCHEM. VOL. 4. ISSUE 11. P. 1779 -1791 | 57 | 62% | 54 |
8 | PERTENBREITER, F , BALZARINI, J , MEIER, C , (2015) NUCLEOSIDE MONO- AND DIPHOSPHATE PRODRUGS OF 2 ', 3 '-DIDEOXYURIDINE AND 2 ', 3 '-DIDEOXY-2 ', 3 '-DIDEHYDROURIDINE.CHEMMEDCHEM. VOL. 10. ISSUE 1. P. 94 -106 | 28 | 78% | 5 |
9 | VENKATACHALAM, TK , SAMUEL, P , UCKUN, FM , (2005) STEREOCHEMICAL INFLUENCE ON LIPASE-MEDIATED HYDROLYSIS AND BIOLOGICAL ACTIVITY OF STAMPIDINE AND OTHER STAVUDINE PHOSPHORAMIDATES.BIOORGANIC & MEDICINAL CHEMISTRY. VOL. 13. ISSUE 5. P. 1763 -1773 | 35 | 83% | 11 |
10 | ORA, M , TAHERPOUR, S , LINNA, R , LEISVUORI, A , HIETAMAKI, E , POIJARVI-VIRTA, P , BEIGELMAN, L , LONNBERG, H , (2009) BIODEGRADABLE PROTECTIONS FOR NUCLEOSIDE 5 '-MONOPHOSPHATES: COMPARATIVE STUDY ON THE REMOVAL OF O-ACETYL AND O-ACETYLOXYMETHYL PROTECTED 3-HYDROXY-2,2-BIS(ETHOXYCARBONYL)PROPYL GROUPS.JOURNAL OF ORGANIC CHEMISTRY. VOL. 74. ISSUE 14. P. 4992 -5001 | 39 | 66% | 6 |
Classes with closest relation at Level 1 |